default

Request a Quote

Product Spotlights

  1. March 04, 2024

    The Colorful History of Chromogenic Media

    The benefits of using chromogenic media include faster results, reliable visual detection and additional testing is possible directly from the media. Compared with the use of conventional culture media, this often results in cost savings from reduced labor time and reduced use of reagents as fewer biochemical and/or serological confirmation tests are required.

    Read More
  2. February 05, 2024

    From Zones of Inhibition to Accurate Results: Mastering the Kirby-Bauer Technique

    The purpose of the Kirby-Bauer disk diffusion susceptibility test is to determine the in vitro susceptibility of bacteria and fungi to various antimicrobial compounds. It is a standardized test that can be performed in a laboratory setting and is a valuable tool for both clinicians and microbiologists.

    Read More
  3. January 12, 2024

    Cases of Group A Streptococcus Continue to Climb

    We began to see an increase in the number of strep throat cases in beginning in late spring of 2023, not only in pediatric patients, but adults as well. Now in December, cases of Group A Streptococcus (GAS) continue to rise. During one newscast out of the Midwest, some physicians say 2023 was the worst year for strep throat that they can remember.
    Read More
  4. January 04, 2024

    Training Guide for NG-Test® CARBA 5

    Carbapenem-resistant Enterobacterales or CRE, are a group of gram-negative bacteria that are resistant to “last line” antibiotics and are very challenging to treat. These microorganisms may confer their resistance via the production of a carbapenemase, an enzyme that inactivates carbapenem antibiotics.

    The five most common types of carbapenemases are KPC, OXA-48-like, VIM, IMP, and NDM.

    Knowing the type of carbapenemase is crucial for therapeutic purposes, infection control, and for preventing outbreaks.

    Read More
  5. November 01, 2023

    New Antimicrobials for Difficult-to-Treat Pathogens: Sulbactam-Durlobactam and Rezafungin

    Healthcare professionals face a constant challenge with ever-evolving bacterial and fungal infections. Multidrug-resistant pathogens threaten the efficacy of existing treatments and highlight the need for new antimicrobial therapies. These microorganisms are typically resistant to the majority of antimicrobial agents, including carbapenems, making them difficult to treat. The Centers for Disease Control and Prevention (CDC) has identified carbapenem-resistant Acinetobacter baumannii (CRAB) as an urgent public health threat.

    Read More
  6. September 30, 2022

    Candida auris - A Deadly Form of Yeast

    Emerging hand in hand with the Pandemic...

    A new 2022 special report from the CDC is sounding the alarm that antimicrobial resistance to some of the most concerning bacteria and fungi significantly increased during the COVID-19 pandemic (1) One such highly drug resistant yeast noted in the report is Candida...

    Read More
  7. March 06, 2020

    COVID-19 Sample Collection Kits for Upper Respiratory Tract Specimens

    Due to the recent 2019 Novel Coronavirus (COVID-19) outbreak, we have
    been getting many inquiries about what type of swabs, media, and kits
    should be used for COVID-19 sample collection prior to testing. Below we
    have a short guide on which COPAN products meet the Centers for Disease
    Control and Prevention (CDC) Interim...

    Read More
  8. February 05, 2020

    CDC Recommends Nasopharyngeal Swabs AND Oropharyngeal Swabs as Suitable for Upper Respiratory Tract Specimens for Investigations of Novel Coronavirus (2019-nCoV)

    COPAN announces a kit that pairs 3mL of UTM® universal viral transport medium and two FLOQSwabs™: one minitip and one regular flocked swab.


    MURRIETA, Calif., Jan. 31, 2020 /PRNewswire/ -- On January 30...

    Read More
  9. April 06, 2018

    67 Lives a Day; How Carrot Broth is Changing Public Health.

    While GBS screenings are the standard in the US and in Europe, there are still parts of the world where the 1 in 5 women globally who carry GBS may not receive screening or treatment. The Bill and Melinda Gates Foundation funded a study led by the London School of Hygiene and Tropical Medicine, involving more than 100 researchers who published a series of 11 research papers reporting on GBS occurances...

    Read More
  10. September 15, 2017

    Saving a Baby One Broth at a Time

    My wife is eight months pregnant and her due date is creeping ever closer with each passing day. In this last month, many preparations are being made in our home. We have assembled the cradle, put away the copious amount of clothes our generous parents have given us (it's our first child), and the house has never been so clean. My wife is also making her own personal preparations. She is eating extremely...

    Read More
  11. April 18, 2017

    No Proteus, No Problem

    Starting off CHROM Month is HardyCHROM SS NoPRO. Before we talk about this innovative new media, let us first take a look at how it came to be.


    Salmonella Salmonella spp. courtesy of the CDC.

    In...

    Read More